Verona pharma to present expanded analysis of phase 2b copd data with ensifentrine at the american thoracic society 2021 international conference

Posters highlight ensifentrine's safety profile and its potential to improve lung function and quality of life irrespective of copd severity posters highlight ensifentrine's safety profile and its potential to improve lung function and quality of life irrespective of copd severity
VRNA Ratings Summary
VRNA Quant Ranking